FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283208194> ?p ?o ?g. }

• W4283208194 endingPage "153473542211054" @default.
• W4283208194 startingPage "153473542211054" @default.
• W4283208194 abstract "Despite the numerous benefits of regular exercise participation for cancer survivors, nearly 60% of survivors do not meet current guidelines. Hospital-based exercise oncology programs may be one strategy to promote exercise engagement as survivors have expressed a preference for exercise programs associated with a cancer hospital. However, follow-up rates in hospital-based exercise oncology programs can be low. Follow-up assessments are a critical component of exercise oncology programs as they determine survivor progress, allow for revision of exercise prescriptions, and demonstrate the effectiveness of the exercise program. Therefore, the purpose of this study was to identify clinical and demographic factors associated with not attending a 12-week follow-up assessment in a hospital-based exercise oncology program.We analyzed data collected from 2016 to 2019 (n = 849) from the Huntsman Cancer Institute's hospital-based exercise oncology program, the Personal Optimism with Exercise Recovery (POWER) program. Cancer survivors completed an assessment at the start of POWER and were encouraged to attend a 12-week follow-up assessment. Factors associated with not attending a 12-week follow-up assessment were identified using logistic regression.Multiple myeloma cancer survivors were more likely (OR 2.33; 95% CI 1.09, 4.98) to not attend a 12-week follow-up assessment, whereas endometrial cancer survivors were less likely (OR 0.39; 95% CI 0.18, 0.87). Greater travel time (OR 2.69; 95% CI: 1.83, 3.96) and distance (OR 2.37; 95% CI: 1.61, 3.49) were associated with not attending a 12-week follow-up assessment. Immunotherapy (OR 1.66; 95% CI 1.02, 2.72), waist circumference (OR 1.01; 95% CI 1.00, 1.02), overweight status per body mass index (OR 1.62; 95% CI 1.11, 2.38), and male sex (OR 1.70; 95% CI 1.23, 2.35) were associated with an increased likelihood of not attending a 12-week follow-up assessment. Survivors with a higher baseline quality of life (OR 0.96; 95% CI 0.93, 0.99) and peak oxygen consumption (OR 0.97; 95% CI 0.95, 0.99) were less likely not to attend a 12-week follow-up assessment.Both clinical and demographic factors were associated with not attending a 12-week follow-up assessment in a hospital-based exercise oncology program. Understanding factors related to follow-up assessment attendance in exercise oncology programs can inform the development of targeted interventions to improve follow-up rate thus maximizing exercise support for cancer survivors." @default.
• W4283208194 created "2022-06-22" @default.
• W4283208194 creator A5014900378 @default.
• W4283208194 creator A5020119459 @default.
• W4283208194 creator A5031236169 @default.
• W4283208194 creator A5039326536 @default.
• W4283208194 creator A5051642639 @default.
• W4283208194 creator A5059006429 @default.
• W4283208194 creator A5065468406 @default.
• W4283208194 creator A5075378954 @default.
• W4283208194 creator A5089571858 @default.
• W4283208194 date "2022-01-01" @default.
• W4283208194 modified "2023-09-27" @default.
• W4283208194 title "Clinical and Demographic Factors Associated With Follow-Up in a Hospital-Based Exercise Oncology Program" @default.
• W4283208194 cites W1970743686 @default.
• W4283208194 cites W1987092264 @default.
• W4283208194 cites W1996069915 @default.
• W4283208194 cites W1999759229 @default.
• W4283208194 cites W2063931484 @default.
• W4283208194 cites W2064076068 @default.
• W4283208194 cites W2069584230 @default.
• W4283208194 cites W2074685643 @default.
• W4283208194 cites W2109659496 @default.
• W4283208194 cites W2509829299 @default.
• W4283208194 cites W2558862781 @default.
• W4283208194 cites W2561994402 @default.
• W4283208194 cites W2732395732 @default.
• W4283208194 cites W2760160481 @default.
• W4283208194 cites W2798034085 @default.
• W4283208194 cites W2807033158 @default.
• W4283208194 cites W2810454451 @default.
• W4283208194 cites W2944390263 @default.
• W4283208194 cites W2947113254 @default.
• W4283208194 cites W2947229233 @default.
• W4283208194 cites W2951071083 @default.
• W4283208194 cites W2952640163 @default.
• W4283208194 cites W2953078460 @default.
• W4283208194 cites W2964216367 @default.
• W4283208194 cites W2967039796 @default.
• W4283208194 cites W2980368443 @default.
• W4283208194 cites W2981263606 @default.
• W4283208194 cites W2991633515 @default.
• W4283208194 cites W3021769786 @default.
• W4283208194 cites W3025014049 @default.
• W4283208194 cites W3046627391 @default.
• W4283208194 cites W3093050186 @default.
• W4283208194 cites W3093858013 @default.
• W4283208194 cites W3110159014 @default.
• W4283208194 cites W3123730373 @default.
• W4283208194 cites W3132493646 @default.
• W4283208194 cites W4220682241 @default.
• W4283208194 doi "https://doi.org/10.1177/15347354221105482" @default.
• W4283208194 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35723412" @default.
• W4283208194 hasPublicationYear "2022" @default.
• W4283208194 type Work @default.
• W4283208194 citedByCount "0" @default.
• W4283208194 crossrefType "journal-article" @default.
• W4283208194 hasAuthorship W4283208194A5014900378 @default.
• W4283208194 hasAuthorship W4283208194A5020119459 @default.
• W4283208194 hasAuthorship W4283208194A5031236169 @default.
• W4283208194 hasAuthorship W4283208194A5039326536 @default.
• W4283208194 hasAuthorship W4283208194A5051642639 @default.
• W4283208194 hasAuthorship W4283208194A5059006429 @default.
• W4283208194 hasAuthorship W4283208194A5065468406 @default.
• W4283208194 hasAuthorship W4283208194A5075378954 @default.
• W4283208194 hasAuthorship W4283208194A5089571858 @default.
• W4283208194 hasBestOaLocation W42832081941 @default.
• W4283208194 hasConcept C121608353 @default.
• W4283208194 hasConcept C126322002 @default.
• W4283208194 hasConcept C143998085 @default.
• W4283208194 hasConcept C151956035 @default.
• W4283208194 hasConcept C15744967 @default.
• W4283208194 hasConcept C1862650 @default.
• W4283208194 hasConcept C204017024 @default.
• W4283208194 hasConcept C2777088508 @default.
• W4283208194 hasConcept C2777179973 @default.
• W4283208194 hasConcept C2780435969 @default.
• W4283208194 hasConcept C71924100 @default.
• W4283208194 hasConcept C77805123 @default.
• W4283208194 hasConceptScore W4283208194C121608353 @default.
• W4283208194 hasConceptScore W4283208194C126322002 @default.
• W4283208194 hasConceptScore W4283208194C143998085 @default.
• W4283208194 hasConceptScore W4283208194C151956035 @default.
• W4283208194 hasConceptScore W4283208194C15744967 @default.
• W4283208194 hasConceptScore W4283208194C1862650 @default.
• W4283208194 hasConceptScore W4283208194C204017024 @default.
• W4283208194 hasConceptScore W4283208194C2777088508 @default.
• W4283208194 hasConceptScore W4283208194C2777179973 @default.
• W4283208194 hasConceptScore W4283208194C2780435969 @default.
• W4283208194 hasConceptScore W4283208194C71924100 @default.
• W4283208194 hasConceptScore W4283208194C77805123 @default.
• W4283208194 hasFunder F4320337351 @default.
• W4283208194 hasLocation W42832081941 @default.
• W4283208194 hasLocation W42832081942 @default.
• W4283208194 hasLocation W42832081943 @default.
• W4283208194 hasOpenAccess W4283208194 @default.
• W4283208194 hasPrimaryLocation W42832081941 @default.
• W4283208194 hasRelatedWork W1770720183 @default.

• next